Answers are grounded in this paper and cite their sources.
Retrospective cohort study shows decreased waitlist mortality and reduced disparities in liver transplant access, indicating improved equity across ABO blood types.
Purpose: We aimed to assess the impact of Acuity Circles (AC) allocation policy on ABO blood type–related disparities in liver transplant waitlist outcomes. Methods: This was a retrospective cohort study using national registry data from 2/2002-9/2023. Adults listed for liver transplant were included, excluding those with hepatocellular carcinoma exceptions and multi-organ listings. Adjusted Fine-Gray competing risk regression was used to evaluate transplant and waitlist mortality outcomes before and after AC policy implementation. Findings: A total 179,376 waitlist candidates were included. Median time to transplant decreased across ABO groups in the post-AC era. In adjusted models, there was a significant change in time to transplant among ABO groups across eras ( p <0.001). There was a 10.7% disparity reduction in time to transplant for type B versus type AB (0.694 SHR post-AC vs. 0.627 SHR pre-AC), and a 4.3% disparity reduction in time to transplant for type O versus type AB (SHR 0.511 post-AC vs. 0.490 pre-AC). While there was a significant reduction in overall waitlist mortality in the post-AC era (SHR 0.605, 95% CI 0.486-0.753, P <0.001), there was no significant interaction between ABO group policy and era ( p =0.74). Conclusion: AC policy yielded more equitable transplant access overall by recipient ABO type, in particular for patients with type B blood.
No takes yet. Share an insight, caveat, or question.
Hatipoğlu et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: